Initial observations in early-onset (< 60 years of age) AD patients revealed that many possessed inherited mutations in the amyloid precursor protein (APP) gene itself or in the genes coding for presenilins 1 or 2 (PS1, PS2), the enzymes that cleave APP to generate the amyloid ß peptide. Here, APP is linked to Alzheimer disease.